TP53 and type 1 diabetes mellitus: GSEA revealed that, compared with non-senescent cells, the AGEs group exhibited significant upregulation of pathways related to proteasome activity, FcεRI-mediated NF-κB activation, ROS signaling, type I diabetes, TP53-regulated death receptor-ligand transcription, and aging (Figure S4a).